• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form FWP filed by KKR & Co. Inc.

    8/4/25 8:12:56 PM ET
    $KKR
    Investment Managers
    Finance
    Get the next $KKR alert in real time by email
    FWP 1 ny20052952x2_fwp.htm FWP
    Free Writing Prospectus
    Filed pursuant to Rule 433
    Supplementing the
    Preliminary Prospectus Supplement dated August 4, 2025 to the
    Prospectus dated May 8, 2024
    Registration No. 333-279233



    KKR & Co. Inc.

    5.100% Senior Notes due 2035

    Final Pricing Term Sheet
    August 4, 2025

    The information in this pricing term sheet should be read together with KKR & Co. Inc.’s preliminary prospectus supplement dated August 4, 2025 (the “Preliminary Prospectus Supplement”), including the documents incorporated by reference therein and the related base prospectus dated May 8, 2024, filed pursuant to Rule 424(b) under the Securities Act of 1933, as amended, Registration No. 333-279233. Terms not defined in this pricing term sheet have the meanings given to such terms in the Preliminary Prospectus Supplement. The information in this pricing term sheet supersedes the information in the Preliminary Prospectus Supplement and the accompanying prospectus to the extent it is inconsistent with the information in the Preliminary Prospectus Supplement or the accompanying prospectus.  All references to dollar amounts are references to U.S. dollars.

    Issuer:
    KKR & Co. Inc.
    Initial Guarantor:
    KKR Group Partnership L.P.
    Securities:
    5.100% Senior Notes due 2035 (the “notes”)
    Ranking:
    Senior unsecured
    Principal Amount Offered:
    $900,000,000
    Trade Date:
    August 4, 2025
    Settlement Date*:
    August 7, 2025 (T+3)
    Maturity Date:
    August 7, 2035
    Coupon:
    5.100%
    Underwriting Discount:
    0.650%
    Price to Public:
    99.752% of principal amount, plus accrued interest, if any, from August 7, 2025 to the date of delivery


    Benchmark Treasury:
    UST 4.250% due May 15, 2035
    Benchmark Treasury Price; Yield:
    100-12; 4.202%
    Spread to Benchmark Treasury:
    T+93 basis points
    Yield to Maturity:
    5.132%
    Interest Payment Dates:
    February 7 and August 7 of each year, commencing on February 7, 2026
    Record Dates:
    Interest payments on the notes will be made to the holders of record at the close of business on January 23 or July 23, as the case may be, immediately preceding such February 7 and August 7, whether or not a business day
    Optional Redemption:
    At any time prior to May 7, 2035 (three months prior to the maturity date) (the “Par Call Date”), at a make-whole price equal to the greater of (1)(a) the sum of the present values of the remaining scheduled payments of principal and interest thereon discounted to the redemption date (assuming the notes matured on the Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate plus 15 basis points less (b) interest accrued to the date of redemption, and (2) 100% of the principal amount of the notes to be redeemed, plus, in either case, accrued and unpaid interest thereon to, but not including, the redemption date. At any time on or after the Par Call Date, at 100% of the principal amount of the notes being redeemed, plus accrued and unpaid interest to, but not including, the redemption date
    Change of Control Offer to Repurchase:
    If a Change of Control (as defined in the Preliminary Prospectus Supplement) occurs, the ratings on the notes are lowered in respect of a Change of Control and the notes are rated below investment grade by S&P Global Ratings Services and Fitch Ratings Inc., the Issuer must offer to repurchase the notes at a purchase price equal to 101% of the principal amount plus any accrued and unpaid interest to, but excluding, the repurchase date
    Day Count/Business Day Convention:
    30/360 Following, Unadjusted
    Gross Proceeds (before expenses and underwriting discount):
    $897,768,000
    Denominations:
    $2,000 and integral multiples of $1,000 in excess thereof
    Expected Ratings**:
    S&P: A / Stable / Fitch: A / Stable
    CUSIP / ISIN:
    48251WAB0 / US48251WAB00
    2


    Joint Book-Running Managers:
    Morgan Stanley & Co. LLC
    Goldman Sachs & Co. LLC
    HSBC Securities (USA) Inc.
    KKR Capital Markets LLC
    UBS Securities LLC
    Co-Managers:
    Academy Securities, Inc.
    Barclays Capital Inc.
    Blaylock Van, LLC
    BMO Capital Markets Corp.
    BNP Paribas Securities Corp.
    BNY Mellon Capital Markets, LLC
    BofA Securities, Inc.
    CIBC World Markets Corp.
    Citigroup Global Markets Inc.
    Credit Agricole Securities (USA) Inc.
    Drexel Hamilton, LLC
    Independence Point Securities LLC
    ING Financial Markets LLC
    J.P. Morgan Securities LLC
    Loop Capital Markets LLC
    Mischler Financial Group, Inc.
    Mizuho Securities USA LLC
    RBC Capital Markets, LLC
    Santander US Capital Markets LLC
    Scotia Capital (USA) Inc.
    SG Americas Securities, LLC
    Siebert Williams Shank & Co. LLC
    SMBC Nikko Securities America, Inc.
    Standard Chartered Bank
    Stern Brothers & Co.
    Strong Capital Markets, LLC
    TD Securities (USA) LLC
    Truist Securities, Inc.
    U.S. Bancorp Investments, Inc.
    Wells Fargo Securities, LLC



    *
    Note: Under Rule 15c6-1 under the Securities Exchange Act of 1934, as amended, trades in the secondary market are required to settle in one business day, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the notes prior to the first business day before the delivery of the notes will be required, by virtue of the fact that the notes initially settle in T+3, to specify an alternate settlement arrangement at the time of any such trade to prevent a failed settlement. Purchasers of the notes who wish to trade the notes during such period should consult their advisors.


    **
    Note: A security rating is not a recommendation to buy, sell or hold securities and should be evaluated independently of any other rating. Each rating is subject to revision or withdrawal at any time by the assigning rating organization.

    3


    The Issuer has filed a registration statement, including the Preliminary Prospectus Supplement and the accompanying prospectus, with the Securities and Exchange Commission for the offering to which this communication relates. Before you invest, you should read the Preliminary Prospectus Supplement and the accompanying prospectus in that registration statement and other documents the Issuer has filed with the Securities and Exchange Commission (the “SEC”) for more complete information about the Issuer and this offering. You may get these documents for free by visiting the SEC’s website at www.sec.gov. Alternatively, the joint book-running managers will arrange to send you the prospectus supplement if you request it by calling Morgan Stanley & Co. LLC toll-free at 1-866-718-1649 or emailing [email protected]; Goldman Sachs & Co. LLC toll-free at 1-866-471-2526 or emailing [email protected]; HSBC Securities (USA) Inc. toll-free at 1-866-811-8049; KKR Capital Markets LLC toll-free at 1-212-230-9433; or UBS Securities LLC toll-free at 1-833-481-0269.

    ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED.  SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM.


    4
    Get the next $KKR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $KKR

    DatePrice TargetRatingAnalyst
    7/14/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    7/9/2025$142.00Buy → Hold
    HSBC Securities
    6/30/2025$150.00Overweight
    Piper Sandler
    5/14/2025$150.00Equal-Weight → Overweight
    Morgan Stanley
    4/15/2025$119.00Hold → Buy
    HSBC Securities
    3/20/2025$150.00 → $141.00Equal Weight → Overweight
    Wells Fargo
    1/30/2025$173.00Buy → Hold
    HSBC Securities
    9/18/2024$148.00Buy
    HSBC Securities
    More analyst ratings

    $KKR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    KKR downgraded by Citizens JMP

    Citizens JMP downgraded KKR from Mkt Outperform to Mkt Perform

    7/14/25 8:40:54 AM ET
    $KKR
    Investment Managers
    Finance

    KKR downgraded by HSBC Securities with a new price target

    HSBC Securities downgraded KKR from Buy to Hold and set a new price target of $142.00

    7/9/25 10:14:31 AM ET
    $KKR
    Investment Managers
    Finance

    Piper Sandler initiated coverage on KKR with a new price target

    Piper Sandler initiated coverage of KKR with a rating of Overweight and set a new price target of $150.00

    6/30/25 8:01:12 AM ET
    $KKR
    Investment Managers
    Finance

    $KKR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Lewin Robert H gifted 2,500 shares, decreasing direct ownership by 0.21% to 1,196,726 units (SEC Form 4)

    4 - KKR & Co. Inc. (0001404912) (Issuer)

    8/15/25 8:00:32 PM ET
    $KKR
    Investment Managers
    Finance

    SEC Form 4 filed by Large owner Kkr Group Partnership L.P.

    4 - KKR & Co. Inc. (0001404912) (Reporting)

    8/14/25 7:00:45 PM ET
    $KKR
    Investment Managers
    Finance

    Co-Chief Executive Officer Bae Joseph Y acquired 1,592 shares (SEC Form 4)

    4 - KKR & Co. Inc. (0001404912) (Issuer)

    8/8/25 8:00:44 PM ET
    $KKR
    Investment Managers
    Finance

    $KKR
    SEC Filings

    View All

    SEC Form 10-Q filed by KKR & Co. Inc.

    10-Q - KKR & Co. Inc. (0001404912) (Filer)

    8/8/25 4:43:19 PM ET
    $KKR
    Investment Managers
    Finance

    SEC Form 144 filed by KKR & Co. Inc.

    144 - KKR & Co. Inc. (0001404912) (Subject)

    8/7/25 6:30:10 PM ET
    $KKR
    Investment Managers
    Finance

    KKR & Co. Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits

    8-K - KKR & Co. Inc. (0001404912) (Filer)

    8/7/25 4:37:55 PM ET
    $KKR
    Investment Managers
    Finance

    $KKR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    THL Announces Agreement to Acquire Headlands Research from KKR

    Strategic Partnership to Advance Site Network Expansion and Accelerate Clinical Trial Innovation THL Partners ("THL"), a premier private equity firm investing in middle market growth companies, today announced the entry into a definitive agreement to acquire Headlands Research ("Headlands" or "the Company"), a leading multinational network of clinical trial sites, from funds managed by leading global investment firm KKR. The strategic partnership between THL and Headlands will fuel Headlands' continued expansion, enhance its technology and centralized infrastructure, and further strengthen its ability to deliver high-quality, diverse clinical trial data for pharmaceutical and biotech spon

    8/14/25 9:00:00 AM ET
    $KKR
    Investment Managers
    Finance

    KKR Leads Financing for Harvest Partners' Growth Investment in Med-Metrix

    KKR, a leading global investment firm, today announced that credit funds and accounts managed by KKR served as lead investors on a financing to support the growth investment from funds managed by Harvest Partners, LP ("Harvest") in Med-Metrix, LLC ("Med-Metrix" or "the Company"), a leading provider of technology-enabled Revenue Cycle Management ("RCM") solutions. KKR Capital Markets also served as Left Lead Arranger and Bookrunner on the transaction. The Company's management team, led by CEO Joseph Davi, will continue to lead Med-Metrix and remain significant owners of the business. Med-Metrix's prior owner, A&M Capital ("AMC"), will retain a minority stake in the Company and invest addit

    8/8/25 7:00:00 AM ET
    $KKR
    Investment Managers
    Finance

    FS KKR Capital Corp. Announces Second Quarter 2025 Results

    Declares Third Quarter 2025 Distribution of $0.70 per share PHILADELPHIA and NEW YORK, Aug. 6, 2025 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK), or the Company, today announced its financial and operating results for the quarter ended June 30, 2025, and that its board of directors has declared a third quarter 2025 distribution of $0.70 per share. Financial and Operating Highlights for the Quarter Ended June 30, 2025(1) Net investment income of $0.62 per share, compared to $0.67 per share for the quarter ended March 31, 2025Adjusted net investment income(2) of $0.60 per sha

    8/6/25 4:15:00 PM ET
    $FSK
    $KKR
    Investment Managers
    Finance

    $KKR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Barakett Timothy R bought $4,127,319 worth of shares (35,000 units at $117.92) (SEC Form 4)

    4 - KKR & Co. Inc. (0001404912) (Issuer)

    5/27/25 8:01:38 PM ET
    $KKR
    Investment Managers
    Finance

    Director Scully Robert W bought $1,503,733 worth of shares (13,250 units at $113.49) (SEC Form 4)

    4 - KKR & Co. Inc. (0001404912) (Issuer)

    5/8/25 7:01:53 PM ET
    $KKR
    Investment Managers
    Finance

    Kkr Alternative Assets Llc bought $50,000,000 worth of Class I Common Stock (1,956,182 units at $25.56) (SEC Form 4)

    4 - KKR & Co. Inc. (0001404912) (Reporting)

    6/6/24 9:02:29 PM ET
    $KKR
    Investment Managers
    Finance

    $KKR
    Leadership Updates

    Live Leadership Updates

    View All

    Harley-Davidson Announces Strategic Partnership with KKR and PIMCO

    Unlocks ~$1.25 billion of discretionary cash for Harley-Davidson and transforms Harley-Davidson Financial Services (HDFS) into a capital-light and derisked business that will continue to originate and service both new and existing retail loans Transaction monetizes HDFS through sale of 4.9% common equity interests to each partner and includes the sale of more than $5 billion of retail loan receivables at a premium to par HDFS has agreed to sell approximately two-thirds of retail loans originated by HDFS annually for a minimum period of five years Values HDFS at ~1.75x price to post-transaction book value and reinforces strategic and financial value of HDFS to Harley-Davidson customers, dea

    7/30/25 7:00:00 AM ET
    $HOG
    $KKR
    Motor Vehicles
    Consumer Discretionary
    Investment Managers
    Finance

    Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors

    Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced the successful completion of a $250 million strategic investment by funds affiliated with KKR, a leading global investment firm. Upon the closing of this transaction, KKR has become the holder of approximately 12% of the common shares of Henry Schein. In connection with the investment, William K. "Dan" Daniel, Executive Advisor to KKR and former Executive Vice President of Danaher Corporation, has officially joined Henry Schein's Board of Directors as an independent director. He joins Max Lin, Partner at KKR and leader of the firm's Healt

    5/16/25 4:10:00 PM ET
    $HSIC
    $KKR
    Medical Specialities
    Health Care
    Investment Managers
    Finance

    KKR Appoints Timothy R. Barakett to Board

    KKR & Co. Inc. (NYSE:KKR) today announced that Timothy R. Barakett has been appointed to the Board of Directors effective March 13, 2025. His appointment will bring the number of independent directors to ten out of a total of fourteen Board seats. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250313966947/en/Timothy R. Barakett (Photo: Business Wire) Mr. Barakett is the Founder and Chief Executive Officer of TRB Advisors, a private investment firm and family office. Prior to founding TRB Advisors in 2010, Mr. Barakett was the Founder and Chief Executive Officer of Atticus Capital, a global investment management firm. Mr. Baraket

    3/13/25 4:30:00 PM ET
    $KKR
    Investment Managers
    Finance

    $KKR
    Financials

    Live finance-specific insights

    View All

    FS KKR Capital Corp. Announces Second Quarter 2025 Results

    Declares Third Quarter 2025 Distribution of $0.70 per share PHILADELPHIA and NEW YORK, Aug. 6, 2025 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK), or the Company, today announced its financial and operating results for the quarter ended June 30, 2025, and that its board of directors has declared a third quarter 2025 distribution of $0.70 per share. Financial and Operating Highlights for the Quarter Ended June 30, 2025(1) Net investment income of $0.62 per share, compared to $0.67 per share for the quarter ended March 31, 2025Adjusted net investment income(2) of $0.60 per sha

    8/6/25 4:15:00 PM ET
    $FSK
    $KKR
    Investment Managers
    Finance

    KKR & Co. Inc. Reports Second Quarter 2025 Results

    KKR & Co. Inc. (NYSE:KKR) today reported its second quarter 2025 results, which have been posted to the Investor Center section of KKR's website at https://ir.kkr.com/events-presentations/. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250731323085/en/ A conference call to discuss KKR's financial results will be held today, Thursday, July 31, 2025 at 9:00 a.m. ET. The conference call may be accessed by dialing (877) 407-0312 (U.S. callers) or +1 (201) 389-0899 (non-U.S. callers); a pass code is not required. Additionally, the conference call will be broadcast live over the Internet and may be accessed through the Investor Cente

    7/31/25 6:50:00 AM ET
    $KKR
    Investment Managers
    Finance

    KKR & Co. Inc. to Announce Second Quarter 2025 Results

    KKR & Co. Inc. (NYSE:KKR) announced today that it plans to release its financial results for the second quarter 2025 on Thursday, July 31, 2025, before the opening of trading on the New York Stock Exchange. A conference call to discuss KKR's financial results will be held on Thursday, July 31, 2025 at 9:00 a.m. ET. The conference call may be accessed by dialing (877) 407-0312 (U.S. callers) or +1 (201) 389-0899 (non-U.S. callers); a pass code is not required. Additionally, the conference call will be broadcast live over the Internet and may be accessed through the Investor Center section of KKR's website at https://ir.kkr.com/events-presentations/. A replay of the live broadcast will be a

    7/14/25 4:15:00 PM ET
    $KKR
    Investment Managers
    Finance

    $KKR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by KKR & Co. Inc.

    SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)

    11/12/24 3:50:17 PM ET
    $KKR
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by KKR & Co. Inc.

    SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)

    11/4/24 11:48:27 AM ET
    $KKR
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by KKR & Co. Inc. (Amendment)

    SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)

    2/13/24 6:32:37 PM ET
    $KKR
    Investment Managers
    Finance